chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient called and asked if we had the Pfizer vaccine in stock, and my tech confirmed that we do. She explained if they are the first of the day, they will need to wait 30 minutes for it to come to room temperature. Patient showed up around 6PM and asked for the Pfizer vaccine. We told her we had it in stock and it was ready to go from previous vaccines in the day. We gave her the form to fill out and asked if she has filled her prior. She has filled a prescription recently so we didn't need to get her license or insurance card. As she was filling out her administration form, she asked about a bug bite on her face and wondered if she can get the vaccine today. I told her it would be fine. The gentleman that was with her (I am assuming the husband) asked if I could look at it and make a recommendation on her to treat it. She stated she took a dose of Benadryl already. I told her to use the Benadryl and to contact the MD for a steroid. She agreed to call in the morning since it is after hours and probably no one is in the office at this time. She completed her paperwork and we sent her into the vaccination room. When I walked in to the consultation room, I asked verbally if she had any other of the vaccines and if this is in fact her first COVID vaccine. She verbally stated yes this is the first and she didn't have one anywhere else. I proceed to ask if she has any questions about this vaccine and to inform her on the procedure about seeing her back in 3 weeks. I vaccinate her and she bleeds. As I am stopping her arm from bleeding and cleaning up the area, she states something along the lines of "I hope I don't have any issues like I did with the J and J shot." I said what, you already had a vaccine and she said ?Yes I had the J and J back in March or April and since the delta variant is out, I am afraid of getting it so I came to get the Pfizer today?. I said you told me you didn't have any other vaccines and now you are saying you did. She confirmed again. I told her I needed to fill out an incident report for my corporate and she said "It's okay don't fill out the report." I stated no I like my job and I am going to fill out the report. I also told her that corporate may be contacting her about this. I stated that I'm not sure what she will experience with getting this after the J and J vaccine, and that we will not be giving her another dose. I put on note on her file here.
pt recv vax & devel small area of rash (size of 50 cent piece on rt thigh);this area was also pink;6NOV97 t100.5-102.5;7NOV97 fever 99, fussy, appetite OK;330PM T101.5;6Pm t103.5 lt ear appeared infected, throat red;8NOV97 diarrhea;rash;
Vaccine given in left arm all side effects were on left side of body . Abnormal side effect was vibration in left groin every 9-24 seconds for 8 hours. It was like my cellphone was in my pocket vibrating on and off for 8 hours
Caller stated she got Moderna vaccine on Saturday and was fine. She stated yesterday she had a few side effects, ie fever, headache, fatigue, which she stated are gone. She stated when she woke up today she was fine but then noticed her eyes were a little bit swollen. She stated she has history of eyes swelling when she eats alot of salt.   No Lot number available at the time of this notification.
unable to move on 12DEC97 thought had flu;next AM still unable to move so taken to ER;hx of heart problems;had pneumonia on adm;14FEB98 devel severe resp distress w/bronchospasm;severe encephalopathy w/quadriparesis dx GBS on 14DEC98;
Redness and swelling at injection site. Has been dizzy and "passed out" approx. 6 times since receiving the vaccine.
DVT - blood clot, found in left leg.  Symptom, leg pain, diagnosed via ultrasound at hospital ,  Lovenox and Pradaxa
developed hives around injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hives in a female patient who received Herpes zoster (Shingrix) (batch number KB97C, expiry date 13th November 2022) for prophylaxis.   Concurrent medical conditions included latex allergy.   On 22nd June 2021, the patient received the 1st dose of Shingrix. In June 2021, less than 2 weeks after receiving Shingrix, the patient experienced injection site hives. The action taken with Shingrix was unknown. On an unknown date, the outcome of the injection site hives was unknown.   It was unknown if the reporter considered the injection site hives to be related to Shingrix.  Additional details were provided are as follows: The patient received 1st dose of Shingrix and developed hives around injection site. The reporter was looking for information about giving only one dose of Shingrix and latex content, as the patient was allergic to latex. The reporter consented to follow up via email or by Fax.
pt recv vax 11APR96 & 15APR sl temp;? swollen glands;3MAY96 phone call concerned about exp to pregnant friend who had chicken pox;6MAY phone call confirm that fiance has  chicken pox although had it @ 5yr old;
Arm Soreness on and off since 1/10/16. Patient let us know of complaint on 1/18/16.
Headache, Dizziness, Shoulder Pain,  Arm pain and Stomach pain started 3-4 days after the vaccine and dizziness has affected the daily activities including work. Been happening for 5 days now
Child receiving Rabies vaccine series for a bat exposure is complaining of "burning episodes 3", post vax, disappeared after 6 hours. "Was most extreme after 1st injection". Consult with health dept and vaccine cooperates. Had same complaints but less severe on 10/22/00; 10/26/00.
Entire Arm was in pain and couldn't move the arm. Very Fatigue. Intense body ache for two weeks, Motrin, I became dizzy and fever and Tylenol around the clock for 4 days and dizziness is 90 per cent. I lost 7 pounds trying to fight the fever and chills. Still have dizziness and can't walk properly. Back pain as well, mild sore throat and a little cough, no diarrhea, sweating and headache. Contacted doctor after 6 days, contacted doctor again.
3RD DOSE MODERNA COVID VACCINE GIVEN 11/30/21, #045J21A; pt to hospital on 8/16/22 with generalized weakness, fatigue, SOB, CP, LE edema; PCP:  Dr. Private, admitted with heart failure exacerbation with a cardiology consult; 8/19/22 pt had reduced left sided movement; testing showed anterior and posterior circulation emboli stroke; pt had a positive COVID test on 8/24/22; she  passed away in the hospital on 9/2/22
No additional AE reported; patient was administered PROQUAD and VARlVAX on 27JAN2022 instead of MMR II and VARlVAX; a 14 year old patient was administered PROQUAD; This spontaneous report was received from a pharmacist and refers to a 14-year-old patient of unknown gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 27-JAN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) (dose/frequency reported as 1) instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (exact dose, dose number, route of administration, vaccination site, lot # and expiration date were not provided). No additional adverse event (AE) reported.
Mom states baby cried evening of vaccine on and off for 2-2.5 hours. On Friday, 6/25/04, baby started crying when picked up or put down (when head moved). On 7/8/04, baby cried all night, had fever; went to ER 7/9/04 6 AM. Fontanel also swollen. Wad diagnosed as pneumonia and given antibiotics. Was not better and went back to ER 7/11. Had spinal tap whihc they said was not accurate due to antibiotics. Was admitted 7/11 for 3 days. Baby started improving with IV antibiotics. No diagnosis made. Baby discharged and has been fine ever since. Mom states crying with movement occurred 6/25/04 until IV antibiotics.
Information has been received from a Doctor of pharmacy concerning a 79 year old male inpatient for decompensate diabetes with hypertension, diabetes and hypercholesterolaemia and no drug reactions or allergies who on 02-APR-2009 was vaccinated inadvertently with PNEUMOVAX (lot # not reported). 0.5ml, intravenously. Concomitant therapy included insulin, lisinopril, NORVASC, GLUCOPHAGE, GLUCOTROL and simvastatin. On 02-APR-2009 the patient experienced abdominal pain, which prolonged hospitalization. At the time of the report on 02-APR-2009 the patient had not recovered. Additional information has been requested.
A serious spontaneous report of stuttering, aphasia, paresthesia, feeling that all her extremities were "paralyzed," falling to the ground and not cognizant of what happened was received from a physician concerning a 42-year-old female subsequent to FLUMIST. The patient has migraine. She has no hypertension, diabetes or history of transient ischemic attack (TIA). Her past medical history included seizure twelve years ago after she bumped her head. At that time, she was on birth control pills. The patient was never diagnosed with epilepsy nor was she given maintenance anti-convulsant drugs. For the past two weeks prior to FLUMIST vaccination on 24-Sep-2008, the patient has been experiencing intermittent episodes of feeling "funny" and intense headache. The patient is on a lot of unreported medications for unknown indications. The patient received FLUMIST for the first time on 24-Sep-2008. The patient reported "feeling funny" and experiencing intense headache prior to FLUMIST vaccination on 24-Sep-2008. After receiving FLUMIST, the patient went home. While at home and about 30-45 minutes after FLUMIST administration, she began to experience stuttering, aphasia and paresthesia. She also felt that all her extremities were "paralyzed," fell to the ground and was not cognizant of what happened. It was not reported whether she had a black-out. The patient was brought by her friends to the local emergency room. At the emergency room, no focal defects were noted. A head CT scan was performed which showed no abnormality. It was determined that there was no evidence of stroke or intracranial bleed. Since FLUMIST administration, the patient's stuttering, aphasia, and paresthesia have occurred intermittently. The patient's stuttering and aphasia would come and go. The paresthesia affected her extremities alternately at various sites. The symptoms of stuttering, aphasia, and paresthesia did get better. The patient was seen in the physician's clinic on 01-Oct-2008. Her physical and neurologic examination did not reveal any abnormality except that the patient would stutter followed by inability to finish a sentence. Her physician could not be certain if she had true aphasia or whether she could not just find the words to say. Head MRI was done on the same day and was normal. A neurology consult was being considered but no appointment was scheduled. As of 01-Oct-2008, the patient's stuttering, aphasia, and paresthesia have worsened. The adverse events of feeling all her extremities were "paralyzed," Falling to the ground and not cognizant of what happened resolved on 24-Sep-2008.
Had flue shot 12/9/99.  On 12/10/99, l/arm injection site was hard and swollen.  Itching at school.  Went to nurse and she said there were hives around the site.  Hives were gone 12/10/99.  Told she shouldn't get the flu vaccine again.
pt recv vax 13FEB97 & 14FEB97 pt had high fever 101;APAP did not help;15FEB97 pt had movement legs, hands, & arms & high fever;take to ER adm to hosp EEG, MRI done;put on phenobarb;
she thinks it could be ITP; platelets were a little lower on the second test; Dripping nose bleed; Fatigue/tired; Abdominal cramping; This is a spontaneous report from a contactable consumer (patient).  A 43-year-old female patient received first dose of BNT162B2 (lot number: EN6204) on 10Mar2021 11:45 (at age of 43-year-old) on right arm at single dose for COVID-19 immunization. Medical history and concomitant medications were none. Caller reports receiving her first vaccine dose in March. Caller is interested in receiving the second dose now and is asking if there would be an issue between the amount of time between first and second doses. Caller reports she experienced a "dripping" nosebleed, fatigue/tired, Abdominal cramping, the day after her first dose on 11Mar2021 and said she reported the safety event. She is scared to get the second dose and can't seem to get any clear information on if she should or not relative to these events. She can't be sure that the abdominal cramping is related to the Pfizer Covid-19 Vaccine because a lot of times she can have that anyway. Regarding the dripping nose bleed she felt like her nose was running so she checked with her hand and found her nose bleeding in a pretty good drip from one nostril; it came on sudden and stopped just as sudden but dripped for maybe a minute or so and filled up a tissue. She verified there has been no emergency room visit or hospitalization relative to these events. Caller verified that there are no relevant concomitant products or other medical conditions to provide for the report. She was not taking any medication at the time, she is on birth control now, but was not at that time. Part of her dilemma was that she got very scared about having the nosebleed. Her primary care physician at the time she called because she has a friend that's a doctor she thinks it could be ITP which is a bleeding disorder you can have from any vaccine. Patient asked her primary care physician for a blood test but he didn't listen; all of her interaction went to a nurse and it turns out they did wrong test for her which she was unaware of initially. They ordered just a regular CBC blood panel. She went to a new doctor for a different reason who looked up her blood panel and said the primary care physician didn't even do the correct panel for someone with a nosebleed, not the one the new doctor would have done. The test done was a basic CBC panel just got what caller guessed were her platelets, white blood cell count, typical tests with no notable results. Prior to having the Pfizer Covid-19 Vaccine she had baseline bloodwork done at her yearly physical so they had that to compare against the CBC done after onset of adverse events. The platelets were a little lower on the second test, the CBC, but still within a normal range. The outcome of event ITP and platelets were a little lower on the second test was unknown. The outcome of other events was recovered on 13Mar2021. The report was reported as non-serious.   Follow-up attempts are completed. No further information is expected.
Injection site became red, warm, & began to itch.  NP observed raised, red site.  Oral antihistamine & topical corticosteroid administered.
This spontaneous report was received from a medical assistant who reported that on 11-DEC-2012 inadvertently administered a dose on an 60 year old male patient of VARIVAX (route, dose, lot number and expiration date were not provided) instated of ZOSTAVAX. No adverse effects has been observed or reported. Additional information has been requested.
Wife stated husband experiencing eye burning, eye pain, redness, blurred vision, generally not feeling well after receiving vaccine on 9-25-11.
Adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reactions). At the time of the report, VACCINATION COMPLICATION (Adverse reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Skin itch in the whole body; and skin discoloration and insomnia; loss of muscular, tinnitus, weight gain, joints and muscles,acne, arthritis, amnesia, blisters, etc.
Patient received 1st vaccine on 1/4/2021 with no complications. Patient received second Covid vaccination February 1 of 2021, on approximately February 10 of 2021 states she developed hives, on her back, her arms, and face, this was associated with pruritus.  Taking hot showers makes "rash worse" and increases itching.  Denies fever or chills Patient denies any changes in laundry detergents, soap, perfumes, liquids or foodstuffs. Patient states hives are less frequent now, they still do appear in diffuse areas occasionally, and this is on a daily basis, she has denied any over-the-counter treatment.
Case number PHEH2015US026930 is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 22 years old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501 and expiry date: May 2016) into the right deltoid on 29 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further problem provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
Red rash and swelled at place were they gave the shot . Really bad head ache. Arm swelled and sore 19 days laters
Chills, low grade fever, body aches, injection site muscle spasm, burning sensation in the chest
Swelling, erythema, pruritis, large swollen area at site, warm, tender, itchy.
Mother accompanied pt for appt. - handed nurse immunization card which showed last tetanus to be 4-4-96.  Given Tdap at approx 845AM with mothers consent.  No adverse effects - pt left office.  Went on line to chart & found out was given 7-20-06.  Called mother & advised no serious effects - may get local reaction (which advice) was obtained from CDC.
rash on my face; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on my face) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on my face). At the time of the report, RASH (rash on my face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported for first dose event.   This case was linked.
~15-30 mins post vaccine dose, patient developed seizure and transferred to outside hospital emergency room via ambulance. Unknown if patient admitted.
Skin hives in my body; This is a spontaneous report from a non-contactable patient. A 70-Year-old non-pregnant female patient received BNT162B2[PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6201] 1st dose on 16Feb2021 at 07.00 pm, and BNT162B2[PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208] 2nd dose on 12Mar2021 at 02.00 pm, solution for injection via Right arm and an unspecified route of administration for Covid 19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient reported as no known allergies. The Concomitant medications included Zolpidem 10mg (Manufacturer unknown), and Escitalopram 10 mg (Manufacturer unknown) for an unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced skin hives on her body on 16Feb2021 at 10.00 am. Therapeutic measures were taken as a result of Hives and included treatment with Cetirizine Hydrochloride from an unknown date. The patient has recovering from the event of skin hives on her body at the time of reporting. No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a Registered Nurse referring to an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 17-MAR-2018, the patients were vaccinated with an improperly stored dose of PEDVAXHIB (route, dose, frequency, and anatomical location were unknown) with one of these lot #s N034005 and expiration date 31-JAN-2020; N016992 and expiration date 07-MAR-2020; N031493 and expiration date 03-OCT-2019 for prophylaxis. The administered doses of the vaccines experienced the temperature excursion at or above 32°F up to 35°F (34.7°F) degrees Fahrenheit for 1 hour. There was a digital data logger involved, and there was a previous temperature excursion at or above 32°F up to 35°F (33.7°F) degrees Fahrenheit for 2 hours and 10 minutes. No adverse effects were reported.
ITCHY, HARD TO BREATH,HEADACH I WAS GIVEN EPIPEN RUCHED TO ED FOR FUTHER TREATMENT
Dev high fever 106, red spot rash head to toe, fussy weak like cry-taken to ER; Sp tap & bld work - WBC 17,000; Dx w/viral illness;
Two days post vax, pt presented with cellulitis of upper right leg approximately 8 X 4 cm, hot and painful to touch. Pt treated with Augmentin.
Dose 1: Arm soreness starting the evening of the injection lasting about 3 days, dizziness  the evening of the injection, fatigue the day after the injection, headache on D3.  Dose 2:  Arm soreness D2 and 3, Chills, body aches and fatigue on D2.   No fever after either shot.
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
This spontaneous report was received from a other health professional refers to a patient of unknown age. On 16-SEP-2014 the patient was vaccinated with ROTATEQ, lot # K001935; expiry: 08-DEC-2015 (dose, dose # and route unspecified). No concomitant medications were reported. On 16-SEP-2014, it was reported that the patient was exposed to temperature outside of the proper storage range. No adverse effect reported. The outcome of were exposed to temperature outside of the proper storage range and no adverse effect reported is unknown. There was no product quality complaint (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
Patient is a 12 year old male and should have received his second dose of the Pfizer vaccine for ages 12 and above. Instead the patient received a dose of the Pfizer formulation for ages 5-11. There was no reported adverse event. The parents were notified of the administration of the incorrect vaccine formulation and that the patient received a smaller than intended dose. After consulting with the manufacturer the provider recommends that the child come back to complete the intended series in 21 days. Parents are in agreement.